Comparison of Postoperative Delirium in Elders Anaesthetised With Midazolam and Without Midazolam
NCT ID: NCT05456230
Last Updated: 2022-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11927 participants
OBSERVATIONAL
2020-04-01
2022-07-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients
NCT05466279
Effect of Remimazolam on Postoperative Delirium
NCT06180876
Impact of Anesthesia Maintenance Methods on Incidence of Postoperative Delirium
NCT02662257
Sevoflurane and Propofol Anesthesia on Postoperative Delirium
NCT01995214
Effects of Volatile Anaesthetics on Incidence of Postoperative Depression and Anxiety in Elderly Patients
NCT06307717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The demographic data of the patients,type and site of surgery will be noted. Preoperative hemoglobin, serum electrolytes and blood urea will be recorded. The intraoperative factors like duration of surgery and anaesthesia,use of intravenous fluids ,blood loss, number blood units transfused and opioid use will be studied at the time of surgery. The time to emergence and extubation following the completion of surgery will be noted.
The postoperative factors like postoperative pain, nausea and vomiting, fever,hemoglobin,serum electrolytes and blood urea will be noted.
Preoperative and postoperative pain will be assessed using the numerical rating score on a scale of one to ten.
The association of various preoperative,intraoperative and postoperative factors with POD will be determined.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Midazolam
Midazolam as a premedication was given as the patient is taken to the operating room and typically within 15 minutes of anesthetic induction.
Midazolam
Midazolam as a premedication was given as the patient is taken to the operating room and typically within 15 minutes of anesthetic induction.
Non-Midazolam
Midazolam was not given during the operation.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Midazolam
Midazolam as a premedication was given as the patient is taken to the operating room and typically within 15 minutes of anesthetic induction.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tiantan Hospital
OTHER
Peking University First Hospital
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Xiangya Hospital of Central South University
OTHER
Beijing Anzhen Hospital
OTHER
China-Japan Friendship Hospital
OTHER
Fudan University
OTHER
Central South University
OTHER
Peking University People's Hospital
OTHER
Zhejiang University
OTHER
Sun Yat-sen University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Taihe Hospital
OTHER
The Affiliated Hospital Of Guizhou Medical University
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Zhejiang Provincial People's Hospital
OTHER
Chinese PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weidong Mi
Director (Cheif expert of National key research and development program of China 2018YFC2001900)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weidong Mi, PhD
Role: STUDY_CHAIR
Chinese PLA General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PLAGH-POD-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.